Raising the Bar for Advanced Drug Delivery

Find out more about our fully streamlined solutions for advanced drug delivery at the 2018 BIO International Convention

June 4-7 | Booth 2525 | Boston, USA 

Device Design & Development

Device Design & Development

Patient-centric designs based on human factors studies

World-class solutions for high volume and high viscosity formulations

Innovative cartridge-based auto injectors with Needle Isolation Technology (NIT®)

Advanced technology for next-generation drug formulations

High-quality and high-volume manufacturing for faster commercialization

Final Assembly, Labeling & Packaging

Final assembly equipment for cartridge or syringe based drug delivery systems

Total integration between device and machine design and development

Labeling equipment designed for SHL devices

Secondary packaging and/or kitting of assembled, labeled devices

Controlled room temperature (CRT) and cold room storage

Process Development

Analytical Sciences: design, development, validation and transfer of test equipment and test methods, syringe characterization, feasibility testing, transportation and aging studies 

Statistics: statistical services assuring optimal control strategy

Project Management: design and planning of tech transfer activities, establishing and tracking of    milestones and direct partnering with clients during the entire process

Final Assembly, Labeling & Packaging

Process Development

Go to article: Home | Invest in TechGo to article: In this issueGo to article: Gerteis Company InsightGo to article: GerteisGo to article: ContentsGo to article: DJAGo to article: NewsGo to article: MedelpharmGo to article: Biotech M&A: will the 2018 surge last?Go to article: NSFGo to article: Can the gene and cell therapy revolution scale up?Go to article: Haselmeier GmbH Company InsightGo to article: Haselmeier GmbH Go to article: Gut instinct: how common drugs affect the microbiomeGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Tracing the story of mumps: a timelineGo to article: Molnar Company InsightGo to article: MolnarGo to article: Inside Swiss pharma: the ideal environment for successGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: MoehsGo to article: Could digital tech unlock billions in savings for pharma companies?Go to article: EcocoolGo to article: CRISPR: a seismic shift in gene editingGo to article: Mestra AG (Endress + Hauser)Go to article: EventsGo to article: Pfanstiehl Inc Company InsightGo to article: Pfanstiehl Inc.Go to article: Next issueGo to article: Niconex Medical LtdGo to article: Alpex Pharma SAGo to article: Pall Biotech Company InsightGo to article: Pall BiotechGo to article: AtoZ-CRO GmbHGo to article: WIKA - Disaster preventionGo to article: Bea TechnologiesGo to article: BaxterGo to article: SuezGo to article: Raland Compliance Partners